| Including intangible costs into the cost-of-illness approach: a method refinement illustrated based on the PM2.5 economic burden in China |
55 |
| Economic burden of stroke: a systematic review on post-stroke care |
39 |
| How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity |
30 |
| Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries |
28 |
| Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries |
19 |
| Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study |
13 |
| Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare |
12 |
| Investigating social inequalities in older adults' dentition and the role of dental service use in 14 European countries |
12 |
| The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach |
11 |
| A healthy immigrant effect or a sick immigrant effect? Selection and policies matter |
11 |
| What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews |
10 |
| The effect of online gambling on gambling problems and resulting economic health costs in Germany |
10 |
| The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England |
10 |
| Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set |
10 |
| Estimating the marginal cost of a life year in Sweden's public healthcare sector |
9 |
| Good jobs, good pay, better health? The effects of job quality on health among older European workers |
9 |
| Cost-utility and cost-effectiveness of physical exercise during adjuvant chemotherapy |
9 |
| Determinants of catastrophic health expenditure in Nigeria |
9 |
| Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death? |
8 |
| A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases |
8 |
| Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial |
7 |
| A head-to-head comparison of five-level (EQ-5D-5L-Y) and three-level EQ-5D-Y questionnaires in paediatric patients |
7 |
| Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review |
7 |
| Experience-based utility and own health state valuation for a health state classification system: why and how to do it |
7 |
| A new method for valuing health: directly eliciting personal utility functions |
7 |
| Psychometric properties of the Hungarian version of the eHealth Literacy Scale |
7 |
| Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age |
6 |
| Design and effects of outcome-based payment models in healthcare: a systematic review |
6 |
| Unemployment and suicide in Italy: evidence of a long-run association mitigated by public unemployment spending |
6 |
| Unemployment, unemployment duration, and health: selection or causation? |
6 |
| Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art |
6 |
| Corruption costs lives: evidence from a cross-country study |
6 |
| Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study |
5 |
| A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy |
5 |
| Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia |
5 |
| Incorporating equity in economic evaluations: a multi-attribute equity state approach |
5 |
| Cost-of-illness studies in nine Central and Eastern European countries |
5 |
| Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis |
5 |
| The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys |
4 |
| Preferences for home- and community-based long-term care services in Germany: a discrete choice experiment |
4 |
| The effectiveness of a population-based skin cancer screening program: evidence from Germany |
4 |
| Effects of pay-for-performance for primary care physicians on diabetes outcomes in single-payer health systems: a systematic review |
4 |
| Unmet medical needs in ambulatory care in Hungary: forgone visits and medications from a representative population survey |
4 |
| An 8-step framework for implementing time-driven activity-based costing in healthcare studies |
4 |
| Who gains the most from improving working conditions? Health-related absenteeism and presenteeism due to stress at work |
4 |
| Structured physiotherapy including a work place intervention for patients with neck and/or back pain in primary care: an economic evaluation |
4 |
| Estimating an exchange rate between the EQ-5D-3L and ASCOT |
4 |
| Systematic review of model-based economic evaluations of heart valve implantations |
4 |
| Impact of late and prolonged working life on subjective health: the Swedish experience |
4 |
| Beyond QALYs: Multi-criteria based estimation of maximum willingness to pay for health technologies |
4 |
